Materias dentro de su búsqueda.
Mostrando 56,441 - 56,460 Resultados de 58,773 Para Buscar '"Her"', tiempo de consulta: 0.33s Limitar resultados
  1. 56441
    “…Losses of 5q33.3–q4 and 18p11.31 and gains of 6p25.1–p25.2 and Xp11.4 were associated with HER2 amplification. No correlations between DNA copy number changes and clinical response to AC were found. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Texto
    Microarray-based comparative genomic hybridisation of breast cancer patients receiving neoadjuvant chemotherapy
  2. 56442
    “…Protein expression profiles were generated for Ki67, Mcm2, geminin, HER-2, ER and PR in a series of reduction mammoplasty (n=18) and breast cancer specimens (n=120), and compared to clinicopathological parameters. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Texto
    DNA replication licensing and cell cycle kinetics of normal and neoplastic breast
  3. 56443
    “…We examined the potential of quantitative epidermal growth factor receptor (EGFR, synonym: c-erbB-1) and c-erbB-2 (synonym: HER2/neu) mRNA expression to predict minor or major histopathologic response to neoadjuvant radiochemotherapy (cis-platinum, 5-FU, 36 Gy), followed by radical surgical resection, in patients with oesophageal cancer. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Texto
    Quantitative c-erbB-2 but not c-erbB-1 mRNA expression is a promising marker to predict minor histopathologic response to neoadjuvant radiochemotherapy in oesophageal cancer
  4. 56444
    “…The worst RFS was observed for the subgroup of patients with endocrine nonresponsive and HER2-negative breast cancer (2-year RFS: 57% in NIBC and 57% in IBC) A high Ki-67 labelling index (>20% of the invasive tumour cells) and the presence of peritumoral vascular invasion (PVI) significantly correlated with poorer RFS in overall (HR 2.69, 95% CI: 1.61–4.50 for Ki-67>20% and HR 2.27, 95% CI: 1.42–3.62 for PVI). …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Texto
    Factors that predict early treatment failure for patients with locally advanced (T4) breast cancer
  5. 56445
    “…Inappropriate signalling through the EGFR and ErbB2/HER2 members of the epidermal growth factor family of receptor tyrosine kinases is well recognised as being causally linked to a variety of cancers. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Texto
    Targeting ErbB2 and ErbB3 with a bispecific single-chain Fv enhances targeting selectivity and induces a therapeutic effect in vitro
  6. 56446
    “…No patient flared while his/her uNTX/uCr remained suppressed. We propose that pamidronate is an effective second-line therapy in persistent CRMO.…”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Texto
    Dramatic pain relief and resolution of bone inflammation following pamidronate in 9 pediatric patients with persistent chronic recurrent multifocal osteomyelitis (CRMO)
  7. 56447
    “…She fell very sick and I came out of school for a full term to look after her. I was treating Jjajja but she was not getting better. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Texto
    "They don't care what happens to us." The situation of double orphans heading households in Rakai District, Uganda
  8. 56448
    “…Tumour phenotypes were analysed by immunohistochemistry on tissue microarrays using selected biomarkers (ER, PR, HER-2, EGFR, CK5/6, CK8, CK18). RESULTS: Classification of genomic profiles through cluster analysis revealed four subgroups, three of which displayed high genomic instability indices (GII). …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Texto
    Genomic profiling of breast tumours in relation to BRCA abnormalities and phenotypes
  9. 56449
    “…BACKGROUND: On theoretical grounds, the age of the grandmother and the age of the mother at delivery of her daughter may affect the breast cancer risk of the granddaughter. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Texto
    Age of mother and grandmother in relation to a subject's breast cancer risk
  10. 56450
    “…METHODS: We computed breast cancer FRR for subtypes of breast cancer by comparing breast cancer incidence in relatives of breast cancer cases from a population-based series with known estrogen receptor (ER), progesterone receptor (PR) or human epidermal growth factor receptor 2 (HER2) status with that expected from the general population. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Texto
    Familial relative risks for breast cancer by pathological subtype: a population-based cohort study
  11. 56451
    “…In addition, 917 invasive and 155 non-invasive breast cancer cases were analysed by immunohistochemistry for Mb expression and correlated to clinicopathological parameters and basal molecular characteristics including oestrogen receptor-α (ERα)/progesteron receptor (PR)/HER2, fatty acid synthase (FASN), hypoxia-inducible factor-1α (HIF-1α), HIF-2α, glucose transporter 1 (GLUT1) and carbonic anhydrase IX (CAIX). …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Texto
    Endogenous myoglobin in human breast cancer is a hallmark of luminal cancer phenotype
  12. 56452
    “…RESULTS: We show that in ER negative basal and HER2+ breast cancer, gene expression modules reflecting T-cell helper-1 (Th1) and T-cell helper-2 (Th2) mediated immune responses play antagonistic roles as major risk factors for distant metastasis. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Texto
    Improved prognostic classification of breast cancer defined by antagonistic activation patterns of immune response pathway modules
  13. 56453
    “…CHIP is implicated in the modulation of estrogen receptor (ESR1) and Her-2/neu (ERBB2) stability. LOX (lysyl-oxidase) serves intracellular roles and catalyses the cross-linking of extracellular matrix (ECM) collagens and elastin. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Texto
    Prognostic implications of carboxyl-terminus of Hsc70 interacting protein and lysyl-oxidase expression in human breast cancer
  14. 56454
    “…Clinical literature documents an inverse relationship between a person’s history of tobacco use and his or her susceptibility to Parkinson’s disease; this may also result from up-regulation. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Texto
    Nicotine up-regulates α4β2 nicotinic receptors and ER exit sites via stoichiometry-dependent chaperoning
  15. 56455
    “…Hormone receptor negative (HRneg) breast cancers, particularly those lacking HER2/ErbB2 overexpression and known as triple-negative (Tneg) cases, are heterogeneous and generally aggressive breast cancer subsets in need of prognostic subclassification, since most early stage HRneg and Tneg breast cancer patients are cured with conservative treatment yet invariably receive aggressive adjuvant chemotherapy. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Texto
    A multigene predictor of metastatic outcome in early stage hormone receptor-negative and triple-negative breast cancer
  16. 56456
    “…However, despite the significant success of therapy in breast and ovarian carcinomas with anti-HER2 mAbs as well as in non-Hodkin B cell lymphomas with anti-CD20 mAbs, certain B cell malignancies such as B chronic lymphocytic leukaemia (B-CLL) respond poorly to anti-CD20 mAb, due to the low surface expression of this molecule. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Texto
    Antitumour effects of single or combined monoclonal antibodies directed against membrane antigens expressed by human B cells leukaemia
  17. 56457
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Lead, cadmium and aluminum in Canadian infant formulae, oral electrolytes and glucose solutions
  18. 56458
    “…In addition, the full model containing 19 CNIs significantly improved prognostication separately for ER–, HER2+, luminal B, and triple negative tumors over clinical variables alone. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Selective Genomic Copy Number Imbalances and Probability of Recurrence in Early-Stage Breast Cancer
  19. 56459
    “…The frequency of alterations was KRAS mutations (8%), EGFR mutations (0%) and HER2 amplification (19%). CONCLUSION: In patients with Eso/GEJ adenocarcinoma, mFOLFOX6 and erlotinib is active, has an acceptable toxicity profile and FOLFOX±erlotinib could be considered for further development.…”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Phase II trial of modified FOLFOX6 and erlotinib in patients with metastatic or advanced adenocarcinoma of the oesophagus and gastro-oesophageal junction
  20. 56460
    “…High miR-34a expression associated with poor prognostic factors for breast cancer: positive nodal status (p = 0.006), high tumour grade (p<0.0001), ER-negativity (p = 0.0002), HER2-positivity (p = 0.0002), high proliferation rate (p<0.0001), p53-positivity (p<0.0001), high cyclin E (p<0.0001) and γH2AX (p<0.0001). …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    MiR-34a Expression Has an Effect for Lower Risk of Metastasis and Associates with Expression Patterns Predicting Clinical Outcome in Breast Cancer
Herramientas de búsqueda: RSS